Friday, February 5, 2016

FDA's Woodcock Fears Biosimilars Explosion

Pharmacy Practice News-20 minutes ago
A persistent funding gap at the FDA is hampering the agency's ability to review the surge of biosimilars applications, Janet Woodcock, MD told a ... A link to this

No comments: